Timing of Dexamethasone Initiation and Its Impact on the Outcome of COVID-19 Patients
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Early dexamethasone administration in severe COVID-19 patients improved discharge rates. Late initiation and higher doses were associated with increased mortality, highlighting the importance of optimal corticosteroid treatment strategies.
Area Of Science
- Medical Research
- Infectious Diseases
- Pharmacology
Background
- COVID-19, a global pandemic, presents with severe respiratory distress.
- Corticosteroids, particularly dexamethasone, are recommended for severe cases.
- Optimal timing and dosage of dexamethasone for COVID-19 patients require further investigation.
Purpose Of The Study
- To investigate the impact of dexamethasone timing, dosage, and route of administration on COVID-19 outcomes.
- To identify predictors of mortality and discharge in severe COVID-19 cases.
Main Methods
- Retrospective cohort study at King Abdulaziz Medical City, Riyadh, Saudi Arabia.
- Data extracted from the BestCare database for 791 COVID-19 patients.
- Statistical analysis of dexamethasone administration parameters and patient outcomes.
Main Results
- Early dexamethasone administration correlated with significantly higher discharge rates (p < 0.001).
- Late dexamethasone initiation and doses >6 mg were associated with increased mortality.
- Intravenous administration linked to higher mortality; age and ventilation needs were strong predictors.
Conclusions
- Dexamethasone timing, dosage, and route significantly impact COVID-19 outcomes.
- Early dexamethasone use is associated with better patient discharge.
- Age and ventilation requirements are critical mortality predictors in severe COVID-19.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...